These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6753889)

  • 1. Azathioprine dosage schedule and rejection episodes in renal transplant recipients.
    Lennard L; Brown CB; Fox M; Maddocks JL
    Br J Clin Pharmacol; 1982 Oct; 14(4):567-9. PubMed ID: 6753889
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract]   [Full Text] [Related]  

  • 4. Is azathioprine necessary in renal transplantation?
    Sheriff MH; Yayha T; Lee HA
    Lancet; 1978 Jan; 1(8056):118-20. PubMed ID: 87552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
    [No Abstract]   [Full Text] [Related]  

  • 6. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 7. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
    Carpenter CB; Milford EL; Kirkman RL; Strom TB; Lazarus JM; Tilney NL
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):261-5. PubMed ID: 3927537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
    Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
    Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
    Collier DS; Calne RY; De Curtins M; Thiru S; White DJ; Jamieson NV; Thick M; Barroso E
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective study of cyclosporine monitoring in renal transplantation.
    Lindholm A
    Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 17. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
    Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1589-90. PubMed ID: 2652517
    [No Abstract]   [Full Text] [Related]  

  • 19. Is a "low" dose of prednisone better than a "high" dose at the time of renal transplantation?
    Stabile C; Vincenti F; Garovoy M; Duca R; Melzer J; Feduska NJ; Salvatierra O; Amend WJ
    Braz J Med Biol Res; 1986; 19(3):355-66. PubMed ID: 3297218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.
    Spielberger M; Aigner F; Schmid T; Bösmüller C; Königsrainer A; Margreiter R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):169-70. PubMed ID: 3291236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.